Low lipoprotein lipase mass in preheparin serum of type 2 diabetes mellitus patients and its recovery with insulin therapy

Diabetes Research and Clinical Practice

Volumn 56, Issue 3, 2002, Pages 181-187

  Miyashita, Yoh ^a   Shirai, Kohji ^a   Itoh, Yoshiaki ^a   Sasaki, Hidehisa ^a   Totsuka, Mitsuya ^a   Murano, Takeyoshi ^a   Watanabe, Hitoshi ^a  

^a TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

Author keywords

Insulin therapy; Preheparin LPL mass; Type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; INSULIN; LIPOPROTEIN LIPASE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HEPARIN; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; REFERENCE VALUES; REGRESSION ANALYSIS;

EID: 0036205494     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(01)00369-2     Document Type: Article

References (16)

1. Lipolytic enzymes and plasma lipoprotein metabolism
2. Regulation of the synthesis, processing and translocation of lipoprotein lipase
3. Transport of lipoprotein lipase across endothelial cells
4. Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acid
5. Fatty acid control of lipoprotein lipase, a link between energy metabolism and lipid transport
6. Lipoprotein lipase mass and activity in severe hypertriglyceridemia
7. Lipoprotein lipase mass and activity in plasma and there increase after heparin are separate parameters with different relations to plasma lipoproteins
8. Preheparin serum lipoprotien lipase mass level: The effects of age, gender, and types of hyperlipidemias
9. The effect of insulin sensitizer troglitazone, on lipoprotein lipase mass in preheparin serum
10. Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance
11. Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects
12. Insulin increases the synthetic rate and messenger RNA level of lipoprotein lipase in isolated rat adipocyte
13. Insulin regulation of lipoprotein lipase activity in 3T3-L1 adipocytes is mediated at posttranscriptional and posttranslational levels
14. Clinical efficacy of the direct assay method using polymers for serum high density lipoprotein cholesterols
15. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetic mellitus: relationship to plasma triglyceride metabolism